Free Trial

Protagonist Therapeutics (PTGX) SEC Filings & 10K Form

Protagonist Therapeutics logo
$38.75 +0.26 (+0.68%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$39.89 +1.14 (+2.94%)
As of 02/21/2025 06:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Protagonist Therapeutics SEC Filings

DateFilerForm TypeView
02/20/2025
4:25 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
8:00 AM
Farallon Capital Partners, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SCHEDULE 13G/A
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Protagonist Therapeutics (Subject)
Form SCHEDULE 13G/A
01/17/2025
4:45 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
4:46 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
4:47 PM
MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:07 PM
Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:07 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:08 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:09 PM
Protagonist Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:10 PM
O'Dowd Sarah A (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:11 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:05 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:06 PM
MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:09 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:11 PM
MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:08 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
6:37 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
6:39 PM
MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:40 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:01 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:49 PM
MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:36 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:27 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:51 PM
Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
3:39 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
12:22 PM
Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/16/2024
11:48 AM
Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
09/13/2024
3:35 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
6:38 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
5:15 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:17 PM
Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
3:18 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
6:08 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:31 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:33 PM
Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
3:12 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
3:30 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:30 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:30 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:46 PM
Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Secret financial plot unfolding in Washington DC… [DEVELOPING] (Ad)

What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. You see, I’ve recently uncovered a secret financial plot unfolding in Washington DC…

So please take a moment to watch it now.
05/07/2024
3:51 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/19/2024
7:05 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:30 PM
Protagonist Therapeutics (Filer)
Form PRE 14A
04/02/2024
7:29 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:45 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:45 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:46 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:27 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:32 PM
Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:48 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
7:00 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:02 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:33 PM
Protagonist Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PTGX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners